Clinical Trial Update: Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a recombinant human serum albumin–granulocyte colony-stimulating factor fusion protein for chemotherapy-induced neutropenia has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein (recombinant human serum albumin–granulocyte colony-stimulating factor fusion protein)

Snippet

Sponsor: Tianjin SinoBiotech Ltd. | Conditions: Chemotherapy-induced Neutropenia | Phase 2 | Status: COMPLETED